Market revenue in 2023 | USD 96.6 million |
Market revenue in 2030 | USD 259.6 million |
Growth rate | 15.2% (CAGR from 2023 to 2030) |
Largest segment | Hydrogels |
Fastest growing segment | Nanofiber Based Scaffolds |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Tecan Group AG, Becton Dickinson & Co, Medtronic PLC, Matricelf Ltd, Corning Inc, Avacta Group PLC, Vericel Corp, NuVasive, Allergan, ReproCELL, 3D Biotek, Xanofi, Molecular Matrix, Pelo Biotech, Azenta Life Sciences, Akron Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to scaffold technology market will help companies and investors design strategic landscapes.
Hydrogels was the largest segment with a revenue share of 41.51% in 2023. Horizon Databook has segmented the China scaffold technology market based on hydrogels, polymeric scaffolds, micropatterned surface microplates, nanofiber based scaffolds covering the revenue growth of each sub-segment from 2018 to 2030.
China's scaffold technology market is expected to witness immense growth over the forecast period, due to increasing awareness about public health issues and increasing disposable income. The use of scaffold technology in biomedical research, drug discovery, and regenerative medicine in China is expected to increase over the coming years.
Moreover, the presence of funding bodies such as Tianjin Municipal Science and Technology Commission and Administrative Commission of the Tianjin Economic Technological Development Area can enable increased undertaking of cell-based research projects in this country.
A large number of national and international companies are initiating agreements & partnerships in regenerative medicine, stem cell research, and drug discovery. For instance, in November 2016, China Southeast University Institute of Life Sciences entered into a joint research project with Boehringer Ingelheim to develop a treatment method by regenerating hair cells from inner ear stem cells, for the treatment of hearing loss.
Horizon Databook provides a detailed overview of country-level data and insights on the China scaffold technology market , including forecasts for subscribers. This country databook contains high-level insights into China scaffold technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account